Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

A baby had a unique skin condition with a pale patch and surrounding dark hairs, not linked to other health issues.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning.

Thallium poisoning can cause hair loss, skin rashes, and nerve damage, and can be fatal if not correctly diagnosed and treated.

Monitoring for adverse effects in clinical treatments is crucial.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The book gives a basic overview of mesotherapy and fat-dissolving injections but lacks detailed guidance and effectiveness comparisons for practitioners.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Non-immune factors play a significant role in alopecia areata.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

The treatment combination is effective and generally safe for lung cancer.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

A gluten-free diet improves growth and reduces symptoms in children with celiac disease.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

No cure for female pattern hair loss, but various effective treatments exist.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.